In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1123492
Abstract: Introduction Ependymomas (EPN) are the third most common malignant brain cancer in children. Treatment strategies for pediatric EPN have remained unchanged over recent decades, with 10-year survival rates stagnating at just 67% for children aged… read more here.
Keywords: derived orthotopic; loss; patient; patient derived ... See more keywords